First National Trust CO 180 Life Sciences Corp. Transaction History

First National Trust CO

  • $2.56 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
BUY
$5.11 - $10.81 $97,090 - $205,390
19,000 New
19,000 $103,000
Q2 2021

Aug 06, 2021
SELL
$6.7 - $11.98 $80,400 - $143,760
-12,000 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$2.51 - $6.96 $30,119 - $83,520
12,000 New
12,000 $79,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track First National Trust CO Portfolio

Follow First National Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email